Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

Detalles Bibliográficos
Autores principales: Beechinor, R., Palumbo, A., Chew, H.K., Arora, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897179/
https://www.ncbi.nlm.nih.gov/pubmed/35131650
http://dx.doi.org/10.1016/j.esmoop.2022.100393
_version_ 1784663348228390912
author Beechinor, R.
Palumbo, A.
Chew, H.K.
Arora, M.
author_facet Beechinor, R.
Palumbo, A.
Chew, H.K.
Arora, M.
author_sort Beechinor, R.
collection PubMed
description
format Online
Article
Text
id pubmed-8897179
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88971792022-03-06 Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients Beechinor, R. Palumbo, A. Chew, H.K. Arora, M. ESMO Open Correspondence Elsevier 2022-02-04 /pmc/articles/PMC8897179/ /pubmed/35131650 http://dx.doi.org/10.1016/j.esmoop.2022.100393 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Correspondence
Beechinor, R.
Palumbo, A.
Chew, H.K.
Arora, M.
Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
title Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
title_full Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
title_fullStr Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
title_full_unstemmed Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
title_short Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
title_sort reply to: drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897179/
https://www.ncbi.nlm.nih.gov/pubmed/35131650
http://dx.doi.org/10.1016/j.esmoop.2022.100393
work_keys_str_mv AT beechinorr replytodrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients
AT palumboa replytodrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients
AT chewhk replytodrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients
AT aroram replytodrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients

Ejemplares similares